Activation of yap1 is significantly associated with poor prognosis and cetuximab resistance in colorectal cancer patients

被引：0
|
作者：
Lee, Keun-Wook [1 ]
Lee, Sung Sook [2 ]
Kim, Sang-Bae [2 ]
Park, Yun-Yong [2 ]
Sohn, Bo Hwa [2 ]
Lee, Hyun-Sung [2 ]
Lee, Ju-Seog [2 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea
[2] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-4734
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4734
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Significant Association of Oncogene YAP1 with Poor Prognosis and Cetuximab Resistance in Colorectal Cancer Patients
    Lee, Keun-Wook
    Lee, Sung Sook
    Kim, Sang-Bae
    Sohn, Bo Hwa
    Lee, Hyun-Sung
    Jang, Hee-Jin
    Park, Yun-Yong
    Kopetz, Scott
    Kim, Sung Soo
    Oh, Sang Cheul
    Lee, Ju-Seog
    CLINICAL CANCER RESEARCH, 2015, 21 (02) : 357 - 364
  • [2] Activation of YAP1 Is Associated with Poor Prognosis and Response to Taxanes in Ovarian Cancer
    Jeong, Woojin
    Kim, Sang-Bae
    Sohn, Bo Hwa
    Park, Yun-Yong
    Park, Eun Sung
    Kim, Sang Cheol
    Kim, Sung Soo
    Johnson, Randy L.
    Birrer, Michael
    Bowtell, David S. L.
    Mills, Gordon B.
    Sood, Anil
    Lee, Ju-Seog
    ANTICANCER RESEARCH, 2014, 34 (02) : 811 - 817
  • [3] High cytoplasmic YAP1 expression predicts a poor prognosis in patients with colorectal cancer
    Dong, Tianqi
    Yuan, Yuncang
    Xiang, Xudong
    Sang, Shuping
    Shen, Hao
    Wang, Lei
    Yang, Chunyan
    Li, Fangfang
    Li, Hongliang
    Zheng, Shangyong
    PEERJ, 2020, 8
  • [4] Association of YAP1 activation with poor patient prognosis and effect on chemoresistance in gastric cancer
    Lee, Sung Sook
    Oh, Sang Cheul
    Jeong, Woojin
    Lee, Sang Ho
    Kim, Sang-Bae
    Park, Yun-Yong
    Sohn, Bo Hwa
    Cheong, Jae-Ho
    Cho, Jae Yong
    Lim, Jae Yun
    Park, Eun Sung
    Jang, You-Jin
    Mok, Young-Jae
    Jung, WonKyung
    Kim, Baek-Hui
    Lee, Keun-Wook
    Tan, Patrick
    Noh, Sung Hoon
    Ajani, Jaffer A.
    Lee, Ju-Seog
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Increased YAP1 expression is significantly associated with breast cancer progression, metastasis and poor survival
    Qadir, Javeria
    Riaz, Syeda Kiran
    Taj, Kiran
    Sattar, Natasha
    Sahar, Namood-e
    Khan, Jahangir Sarwar
    Kayani, Mahmood Akhtar
    Haq, Farhan
    Arshad Malik, Muhammad Faraz
    FUTURE ONCOLOGY, 2021, 17 (21) : 2725 - 2734
  • [6] YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer
    Jerhammar, Fredrik
    Johansson, Ann-Charlotte
    Ceder, Rebecca
    Welander, Jenny
    Jansson, Agneta
    Grafstrom, Roland C.
    Soderkvist, Peter
    Roberg, Karin
    ORAL ONCOLOGY, 2014, 50 (09) : 832 - 839
  • [7] YAP1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTEN
    Guo, Liwen
    Chen, Yutang
    Luo, Jun
    Zheng, Jiaping
    Shao, Guoliang
    FEBS OPEN BIO, 2019, 9 (03): : 437 - 445
  • [8] Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma
    Ping Li
    Dan Sun
    Xiaoting Li
    Yingjian He
    Wenhui Li
    Jing Zhao
    Ying Wang
    Huan Wang
    Yan Xin
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1765 - 1773
  • [9] Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma
    Li, Ping
    Sun, Dan
    Li, Xiaoting
    He, Yingjian
    Li, Wenhui
    Zhao, Jing
    Wang, Ying
    Wang, Huan
    Xin, Yan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (08) : 1765 - 1773
  • [10] Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells
    Anxo Rio-Vilariño
    Aiora Cenigaonandia-Campillo
    Ana García-Bautista
    Pedro A. Mateos-Gómez
    Marina I. Schlaepfer
    Laura del Puerto-Nevado
    Oscar Aguilera
    Laura García-García
    Carlos Galeano
    Irene de Miguel
    Juana Serrano-López
    Natalia Baños
    María Jesús Fernández-Aceñero
    Juan Carlos Lacal
    Enzo Medico
    Jesús García-Foncillas
    Arancha Cebrián
    British Journal of Cancer, 2024, 130 : 1402 - 1413
12345